Advertisements



Audentes Therapeutics upgraded to Buy from Neutral at Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 11th, 2019

Audentes Therapeutics upgraded to Buy from Neutral at Chardan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 25th, 2019

Audentes Therapeutics upgraded to Buy at Guggenheim on positive AT132 outlook

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 11th, 2019

Audentes Therapeutics initiated with a Neutral at Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 9th, 2018

Audentes Therapeutics initiated with a Neutral at Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 9th, 2018

Audentes Therapeutics upgraded to Buy from Neutral at Mizuho

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 8th, 2018

Esperion Therapeutics upgraded to neutral from underweight at J.P. Morgan

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMar 13th, 2019

Eidos Therapeutics upgraded to Overweight from Neutral at JPMorgan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 27th, 2019

Five Prime Therapeutics upgraded to outperform from neutral at Wedbush

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJan 17th, 2019

Constellation Brands upgraded to Neutral from Sell at Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 9th, 2019

Tempur Sealy upgraded to Buy from Neutral at Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019

NiSource upgraded to Buy from Neutral at Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019

CenterPoint Energy upgraded to Buy from Neutral at Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019

Akari Therapeutics upgraded to buy from neutral at B. Riley FBR

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJan 4th, 2019

Regeneron upgraded to Buy from Neutral at Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 4th, 2019

Incyte upgraded to Buy from Neutral at Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 3rd, 2019

CarMax upgraded to Buy from Neutral at Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 24th, 2018

Orchard Therapeutics upgraded to Buy from Neutral at Goldman Sachs

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 17th, 2018

CytomX Therapeutics upgraded to Buy from Neutral at Goldman Sachs

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

Corcept Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 12th, 2018

National Beverage upgraded to Neutral from Sell at Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 6th, 2018